FUNCTIONAL CONSTIPATION, DYNAMICS OF PRESENTATIONS, DIAGNOSTICS, INDIVIDUAL APPROACHES TO THE TREATMENT
https://doi.org/10.21518/2079-701X-2017-20-92-95
Abstract
The article presents data on functional constipation (FC): the definition (including the one of the last consensus – Rome IV), epidemiology, diagnostics, general approaches to the treatment and the results of using the stimulant drug Slabilen manufactured by the domestic firm Veropharm. 30 patients received the drug, and the positive effect accounted for 90%. The advantage of the drug is a double mechanism action: stimulating and osmotic. No pathological effects have been detected.
About the Author
O. N. Minushkin
Central State Medical Academy of Department of Presidential Affairs of RF.
Russian Federation
Russian Federation
MD, Prof.
Moscow.
References
1. Минушкин О.Н. Хронический запор (определение, эпидемиология, диагностика): современная медикаментозная терапия. Медицинский совет, 2015, 13: 100-105.
2. Garrigues V et al. Prevalence of constipation agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in population in Spain. Am J Epidemiol, 2004, 159: 520-526.
3. Zembo A Camilleri M. Chronic constipation. N Engl J Med, 2003, 349: 1360-1368.
4. Pare P et al. An epidemiological survey of constipation in Canada definitions rates demographics and predictors of health care seeking. Am J gastroenterol, 2001, 96: 3130-3137.
5. Пасечников В.Д. Функциональный запор, обусловленный замедленным транзитом кишечного содержимого. Фарматека, 2003, 10: 16-22.
6. Елизаветина Г.А., Минушкин О.Н. Запоры и некоторые принципы их лечения. Клиническая фармакология и терапия, 1997, 6: 51-53.
Review
For citations:
Minushkin ON. FUNCTIONAL CONSTIPATION, DYNAMICS OF PRESENTATIONS, DIAGNOSTICS, INDIVIDUAL APPROACHES TO THE TREATMENT. Meditsinskiy sovet = Medical Council. 2017;(20):92-95. (In Russ.) https://doi.org/10.21518/2079-701X-2017-20-92-95
Views:
895
Email this article 